Literature DB >> 12006385

Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN.

Jianhua Huang1, Christopher D Kontos.   

Abstract

Phosphatidylinositol (PI) 3-kinase signaling regulates numerous cellular processes, including proliferation, migration, and survival, which are required for neointimal hyperplasia and restenosis. The effectors of PI 3-kinase are activated by the phospholipid products of PI 3-kinase. In this report, we investigated the hypothesis that overexpression of the tumor suppressor protein PTEN, an inositol phosphatase specific for the products of PI 3-kinase, would inhibit the vascular smooth muscle cell (VSMC) responses necessary for neointimal hyperplasia and restenosis. Effects of PTEN were assessed in primary rabbit VSMCs after overexpression with a recombinant adenovirus and compared with uninfected or control virus-infected cells. PTEN was expressed endogenously in VSMCs, and PTEN overexpression inhibited PDGF-induced phosphorylation of p70(s6k), Akt, and glycogen synthase kinase-3-alpha and -beta but not ERK1 or -2. Overexpression of PTEN significantly inhibited both basal and PDGF-mediated VSMC proliferation and migration, the latter possibly due in part to downregulation of focal adhesion kinase. Moreover, PTEN overexpression induced cleavage of caspase-3 and significantly increased apoptosis compared with control cells. Taken together, these results demonstrate that PTEN overexpression potently inhibits the VSMC responses required for neointimal hyperplasia and restenosis. Adenovirus-expressed PTEN may therefore provide a useful tool for the local treatment of these and other vascular proliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006385     DOI: 10.1161/01.atv.0000016358.05294.8d

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

2.  Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.

Authors:  J Shi; M Ju; W A Large; A P Albert
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi.

Authors:  C Henrique Serezani; Steve Kane; Alexandra I Medeiros; Ashley M Cornett; Sang-Hoon Kim; Mariana Morato Marques; Sang-Pyo Lee; Casey Lewis; Emilie Bourdonnay; Megan N Ballinger; Eric S White; Marc Peters-Golden
Journal:  Sci Signal       Date:  2012-02-07       Impact factor: 8.192

Review 4.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

Review 5.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

6.  Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells.

Authors:  Wen Jin; Marpadga A Reddy; Zhuo Chen; Sumanth Putta; Linda Lanting; Mitsuo Kato; Jung Tak Park; Manasa Chandra; Charles Wang; Rajendra K Tangirala; Rama Natarajan
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

7.  VE-statin, an endothelial repressor of smooth muscle cell migration.

Authors:  Fabrice Soncin; Virginie Mattot; Frédéric Lionneton; Nathalie Spruyt; Frédéric Lepretre; Agnès Begue; Dominique Stehelin
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.

Authors:  Seth B Furgeson; Peter A Simpson; Insun Park; Vicki Vanputten; Henrick Horita; Christopher D Kontos; Raphael A Nemenoff; Mary C M Weiser-Evans
Journal:  Cardiovasc Res       Date:  2010-01-05       Impact factor: 10.787

9.  Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats.

Authors:  Kay L H Wu; Chiung-Ai Wu; Chih-Wei Wu; Samuel H H Chan; Alice Y W Chang; Julie Y H Chan
Journal:  Antioxid Redox Signal       Date:  2012-08-16       Impact factor: 8.401

10.  Pulmonary hypertension secondary to left-heart failure involves peroxynitrite-induced downregulation of PTEN in the lung.

Authors:  Yazhini Ravi; Karuppaiyah Selvendiran; Shan K Naidu; Sarath Meduru; Lucas A Citro; Balázs Bognár; Mahmood Khan; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy; Chittoor B Sai-Sudhakar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.